Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration

نویسندگان

  • Marcel Smid
  • F Germán Rodríguez-González
  • Anieta M Sieuwerts
  • Roberto Salgado
  • Wendy J C Prager-Van der Smissen
  • Michelle van der Vlugt-Daane
  • Anne van Galen
  • Serena Nik-Zainal
  • Johan Staaf
  • Arie B Brinkman
  • Marc J van de Vijver
  • Andrea L Richardson
  • Aquila Fatima
  • Kim Berentsen
  • Adam Butler
  • Sancha Martin
  • Helen R Davies
  • Reno Debets
  • Marion E Meijer-Van Gelder
  • Carolien H M van Deurzen
  • Gaëtan MacGrogan
  • Gert G G M Van den Eynden
  • Colin Purdie
  • Alastair M Thompson
  • Carlos Caldas
  • Paul N Span
  • Peter T Simpson
  • Sunil R Lakhani
  • Steven Van Laere
  • Christine Desmedt
  • Markus Ringnér
  • Stefania Tommasi
  • Jorunn Eyford
  • Annegien Broeks
  • Anne Vincent-Salomon
  • P Andrew Futreal
  • Stian Knappskog
  • Tari King
  • Gilles Thomas
  • Alain Viari
  • Anita Langerød
  • Anne-Lise Børresen-Dale
  • Ewan Birney
  • Hendrik G Stunnenberg
  • Mike Stratton
  • John A Foekens
  • John W M Martens
چکیده

A recent comprehensive whole genome analysis of a large breast cancer cohort was used to link known and novel drivers and substitution signatures to the transcriptome of 266 cases. Here, we validate that subtype-specific aberrations show concordant expression changes for, for example, TP53, PIK3CA, PTEN, CCND1 and CDH1. We find that CCND3 expression levels do not correlate with amplification, while increased GATA3 expression in mutant GATA3 cancers suggests GATA3 is an oncogene. In luminal cases the total number of substitutions, irrespective of type, associates with cell cycle gene expression and adverse outcome, whereas the number of mutations of signatures 3 and 13 associates with immune-response specific gene expression, increased numbers of tumour-infiltrating lymphocytes and better outcome. Thus, while earlier reports imply that the sheer number of somatic aberrations could trigger an immune-response, our data suggests that substitutions of a particular type are more effective in doing so than others.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Tumor immunity landscape in non-small cell lung cancer

Even with the great advances in immunotherapy in recent years, the response rate to immune checkpoint inhibitor therapy for non-small cell lung cancer is only about 20%. We aimed to identify new features that would better predict which patients can benefit from an immune checkpoint blocker. This study is based on the publicly available gene expression data from The Cancer Genome Atlas lung canc...

متن کامل

Immune DNA signature of T-cell infiltration in breast tumor exomes

Tumor infiltrating lymphocytes (TILs) have been associated with favorable prognosis in multiple tumor types. The Cancer Genome Atlas (TCGA) represents the largest collection of cancer molecular data, but lacks detailed information about the immune environment. Here, we show that exome reads mapping to the complementarity-determining-region 3 (CDR3) of mature T-cell receptor beta (TCRB) can be u...

متن کامل

Biology of Human Tumors Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer

Purpose: Lymphocytic infiltration of tumors predicts improved survival in patients with breast cancer. Previous studies have suggested that this survival benefit is confined predominantly to the basal-like subtype. Immune infiltration in ovarian tumors is also associated with improved prognosis. Currently, it is unclear what aspects of the immune response mediate this improved outcome. Experime...

متن کامل

Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer.

PURPOSE Lymphocytic infiltration of tumors predicts improved survival in patients with breast cancer. Previous studies have suggested that this survival benefit is confined predominantly to the basal-like subtype. Immune infiltration in ovarian tumors is also associated with improved prognosis. Currently, it is unclear what aspects of the immune response mediate this improved outcome. EXPERIM...

متن کامل

Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment

Long non-coding RNAs (lncRNAs) are emerging as crucial regulators of cellular processes and diseases such as cancer; however, their functions remain poorly characterised. Several studies have demonstrated that lncRNAs are typically disease and tumour subtype specific, particularly in breast cancer where lncRNA expression alone is sufficient to discriminate samples based on hormone status and mo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 7  شماره 

صفحات  -

تاریخ انتشار 2016